Brief: Karolinska Development's Svenska Vaccinfabriken Appoints Richard Bethell As New CEO
Jan 11 (Reuters) - Karolinska Development AB KDEV.ST :
* KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY SVENSKA
VACCINFABRIKEN APPOINTS RICHARD BETHELL AS NEW CEO
* RICHARD BETHELL WILL ASSUME POSITION IMMEDIATELY
* RICHARD IS CURRENTLY CHIEF DEVELOPMENT OFFICER AT STIPE
THERAPEUTICS, A SPIN-OFF COMPANY FROM AARHUS UNIVERSITY IN
DENMARK
Source text for Eikon: ID:nGNE1XrFmq
Further company coverage: KDEV.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue